$AKBA Cashflow Statement | Understand Stock

$AKBA

$0.64 +$0.08 (13.57%) Close

$AKBA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statement of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating Activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Depreciation
Amortization of intangible asset
Intangible asset impairment charge
Interest expense related to sale of future royalties (non-cash)
Bad debt expense
Change in fair value of warrant liability
Non-cash royalty revenue related to sale of future royalties
Amortization of premium/discount on investments
Collaboration revenue in connection with the termination of the Otsuka Agreement (non-cash)
Non-cash research and development expense
Non-cash interest expense
Non-cash operating lease expense
Write-off of property and equipment
Fair value step-up of inventory sold or written off
Non-cash loss on extinguishment of debt
Provision of inventories
Non-cash write-off on termination of lease
Charge for purchase of IPR&D asset
Write-down of inventory
Change in firm purchase commitments
Change in excess inventory purchase commitments
Stock-based compensation expense
Deferred income taxes
Gain on the sale of property and equipment
Change in fair value of embedded debt derivative
Changes in operating assets and liabilities:
Accounts receivable
Inventory
Prepaid expenses and other current assets
Operating lease assets
Other long-term assets
Accounts payable
Accrued expense and other current liabilities
Operating lease liabilities
Deferred revenue
Other long-term liabilities

Net cash provided by (used in) operating activities
Investing Activities:
Purchase of equipment
Purchase of available for sale securities
Proceeds from the maturities of available for sale securities
Proceeds from sales of available for sale securities
Proceeds from the sale of property and equipment
Purchase of IPR&D asset, including transaction costs
Net cash used in investing activities

Financing Activities:
Proceeds from refund liabilities to customers
Proceeds from refund liability to customer
Proceeds from the issuance of debt
Payments of issuance costs related to BlackRock Credit Agreement
Proceeds from the issuance of common stock, net of issuance costs
Proceeds from the sale of stock under employee stock purchase plan
Proceeds from the exercise of common stock options
Retirement of treasury stock
Proceeds from the issuance of debt, net
Principal payments on debt
Repayment of WCF liability
Repayment of liability related to settlement royalties
Repayment of term debt
Net cash provided by (used in) financing activities

Increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of the period
Cash, cash equivalents and restricted cash at end of the period
Supplemental cash flow information
Issuance of warrants in connection with BlackRock Credit Agreement
Cashless exercise of warrants in connection with BlackRock Credit Agreement
Purchase of IPR&D asset included in accrued expenses and other current liabilities
Cash paid for interest

Comments